NEORX CORP
4, 2000-12-08
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MERCHANTS & MANUFACTURERS BANCORPORATION INC, S-4/A, 2000-12-08
Next: WARBURG PINCUS CASH RESERVE FUND, DEFS14A, 2000-12-08


    FORM 4

/ / Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
STATEMENT OF
CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
 
OMB APPROVAL

OMB Number:  3235-0287
Expires: September 30, 1998
Estimated average burden hours per response .... 0.5


1. Name and Address of Reporting Person*   2. Issuer Name and Ticker or Trading Symbol   6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
  Abrams   Paul   G.     NEORX CORPORATION NERX      X  Director       10% Owner

 
         
  (Last)   (First)   (Middle)   3. IRS or Social Security Number of Reporting Person (Voluntary)   4. Statement for Month/Year      X  Officer
  (give title below)
      Other
  (specify below)
  2126 1st Ave, #1602           11/2000     CEO

       
   
(Street)         5. If Amendment, Date of Original (Month/Year)   7. Individual or Joint/Group Filing
(Check Applicable Line)
 X  Form filed by One Reporting Person
     Form filed by More than One Reporting Person
  Seattle   WA   98121                      

  (City)   (State)   (Zip)                      
              Table I — Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security
(Instr. 3)
  2. Transaction Date   3. Transaction Code
(Instr. 8)
  4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
  5. Amount of Securities Beneficially Owned at End of Month   6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
  7. Nature of Indirect Beneficial Ownership
(Instr. 4)
        (Month/ Day/ Year)
    (Instr. 3 and 4)            
              Code   V     Amount   (A) or (D)   Price                  

  Common Stock     11/15/00     M         18,875   A   1.50     170,235     D      

                                                   

                                                   

                                                   

                                                   

                                                   

                                                   

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.   (Over)
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).   SEC 1474 (7-97)

POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION
CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM
DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER.


FORM 4 (Continued)   Table II — Derivative Securities Acquired, Disposed of, or Beneficially Owned
(
e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)
  2. Conversion or Exercise Price of Derivative Security   3. Transaction Date
(Month/Day/Year)
  4. Transaction Code
(Instr. 8)
  5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
  6. Date Exercisable and Expiration Date (Month/Day/Year)
                 
 
                    Code   V     (A)   (D)     Date Exercisable   Expiration Date

Employee Stock Option (Right to Buy)     1.50     11/15/00     M             18,875     (1)   11/15/00

                                             

                                             

                                             

                                             

                                             

                                             

                                             

                                             

                                             

                                             


7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
  8. Price of Derivative Security
(Instr. 5)
  9. Number of Derivative Securities Beneficially Owned at End of Month
(Instr. 4)
  10.   Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
  11.   Nature of Indirect Beneficial Ownership
(Instr. 4)
 
                           
  Title   Amount or Number of Shares                            

  Common Stock   18,875           -0-       D        

                                   

                                   

                                   

                                   

                                   

                                   

                                   

                                   

                                   

                                   

Explanation of Responses:

(1) Exercisable at 25% annually beginning 11/15/1991 in accordance with the vesting schedule of the employee stock option plan.

    /s/ Paul G. Abrams   December 8, 2000
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).  
**Signature of Reporting Person
Paul G. Abrams
 
Date
         
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.        
         
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.       Page 2
SEC 1474 (7-97)




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission